ARPA-H announced it will grant up to $125 million to projects aimed at accelerating the manufacturing of custom RNA-based ...

FDA further tests waters on AI medical devices; Ultragenyx sees its stock crater on Phase 3 trial failure; Brain implants ...

The Current, Gulf States Newsroom, and Verite News — to ask all 64 sheriffs in the state how they’ve spent their opioid ...

Meet the latest partners in Trump’s MFN pricing agreements; Novartis’ roller coaster day; Inside the perimenopause industrial ...

The agency said booth materials for Alar’s investigational ALA-3000 made unsupported safety and efficacy claims and failed to ...

A major MFN pricing loophole; An uptick in parents opting out of vitamin K shots for newborns; BI leans into AI-powered drug ...

A sheriff’s deputy opens the door of an Idaho farmhouse where a newborn baby has just died. It’s almost 10 p.m., but the house is filled with adults and children seated anywhere they can find a spot: ...

Built in collaboration with Google Cloud, Eversana’s platform combines agentic AI orchestration, workflow automation and ...

Novo and Lilly step up fight against counterfeit weight-loss drugs; Updated COVID shots enter the scene; Walmart settles for ...

Omnicom Public Relations Group firm Maslansky + Partners named Keith Yazmir president and Katherine Hettrich and Amanda ...

RNA technology gets public image lift; Lilly acquires another biotech; GOP gambles midterm fortunes on MAHA movement.